Coronary risk estimation in Spain using a calibrated Framingham function (Q44352908)

2 December 2017

Coronary risk estimation in Spain using a calibrated Framingham function (English)

1 reference

2 December 2017

4

1 reference

2 December 2017

1

Jaume Marrugat

1 reference

2 December 2017

Ralph B. D'Agostino Sr.

3

object named as

Ralph D'Agostino

1 reference

2 December 2017

12

William B Kannel

1 reference

2 December 2017

Pascual Solanas

2

1 reference

2 December 2017

José Ordovas

5

1 reference

2 December 2017

Ferran Cordón

6

1 reference

2 December 2017

Rafael Ramos

7

1 reference

2 December 2017

Joan Sala

8

1 reference

2 December 2017

Rafael Masià

9

1 reference

2 December 2017

Izabella Rohlfs

10

1 reference

2 December 2017

Roberto Elosua

11

1 reference

2 December 2017

language of work or name

Spanish

0 references

publication date

1 March 2003

1 reference

Revista Española de Cardiología

2 December 2017

1 reference

2 December 2017

56

1 reference

2 December 2017

253-261

1 reference

2 December 2017

3

1 reference

[Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005]

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Cholesterol and tobacco: classics that withstand the passing of time

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

An updated coronary risk profile. A statement for health professionals.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Estimation of CHD risk in a French working population using a modified Framingham model

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Predicting cardiovascular risk in the elderly in different European countries

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Risk factors and coronary morbimortality in a Mediterranean industrial cohort over 28 years of follow-up. The Manresa Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Coronary risk estimation and treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Challenges for the prevention of primary and secondary stroke: the importance of lowering blood pressure and total cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2803%2976861-4

7 January 2021

10.1016/S0300-8932(03)76861-4

Identifiers

DOI

1 reference

2 December 2017

1 reference